EJNMMI Radiopharm Chem

ISSN	2365-421X
ISSN-L	-
IUID	2f1270d54b7d4751833da480f115300a
Modified	2026-08-20T12:37:17.328Z
Created	2026-08-20T12:37:17.328Z

Year 2025

PubMed DOI Crossref

PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation.

Yashaswini CN, Mitran B, Papadopoulos N, ..., Friedman SL, Eriksson O

EJNMMI Radiopharm Chem 10 (1) 80 [2025-12-13; online 2025-12-13]

Olof Eriksson SciLifeLab Fellow

PubMed DOI Crossref

Extending the shelf life of ⁶⁸Ge/⁶⁸Ga generators via preconcentration of [⁶⁸Ga]GaCl₃ for preclinical application.

Mallapura H, Eriksson O

EJNMMI Radiopharm Chem 10 (1) 76 [2025-11-26; online 2025-11-26]

Olof Eriksson SciLifeLab Fellow

PubMed DOI Crossref

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Obeid K, Bezverkhniaia E, Tolmachev V, Orlova A, Kanellopoulos P

EJNMMI Radiopharm Chem 10 (1) 74 [2025-11-13; online 2025-11-13]

PubMed DOI Crossref

RM2 and DB15 analogues bearing [177Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study.

Kanellopoulos P, Bitzios A, Zelepukin I, ..., Tolmachev V, Orlova A

EJNMMI Radiopharm Chem 10 (1) 50 [2025-07-31; online 2025-07-31]

PubMed DOI Crossref

PET imaging of platelet derived growth factor receptor β in lung fibrosis.

Wegrzyniak O, Lechi F, Rokka J, ..., Eriksson J, Eriksson O

EJNMMI Radiopharm Chem 10 (1) 44 [2025-07-15; online 2025-07-15]

Olof Eriksson SciLifeLab Fellow

PubMed DOI Crossref

Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [18F]MeTz-PEG2-RM26 for positron emission tomography.

Kanellopoulos P, Lundmark F, Abouzayed A, ..., Eriksson J, Orlova A

EJNMMI Radiopharm Chem 10 (1) 14 [2025-03-26; online 2025-03-26]

PubMed DOI Crossref

Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [99mTc]Tc-labeled counterparts be used to estimate dosimetry?

Kanellopoulos P, Yu Q, Abouzayed A, ..., Tolmachev V, Orlova A

EJNMMI Radiopharm Chem 10 (1) 3 [2025-01-17; online 2025-01-17]

Year 2024

PubMed DOI Crossref

Optimized method for fluorine-18 radiolabeling of Affibody molecules using RESCA.

Lechi F, Eriksson J, Odell LR, ..., Zhang B, Eriksson O

EJNMMI Radiopharm Chem 9 (1) 73 [2024-10-26; online 2024-10-26]

Olof Eriksson SciLifeLab Fellow

PubMed DOI Crossref

Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell model.

Durinova A, Smutna L, Barta P, ..., Pavek P, Trejtnar F

EJNMMI Radiopharm Chem 9 (1) 32 [2024-04-18; online 2024-04-18]

PubMed DOI Crossref

Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.

Kanellopoulos P, Mattsson A, Abouzayed A, ..., Maina T, Orlova A

EJNMMI Radiopharm Chem 9 (1) 13 [2024-02-16; online 2024-02-16]

Year 2023

PubMed DOI Crossref

Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β.

Wegrzyniak O, Zhang B, Rokka J, ..., Eriksson J, Eriksson O

EJNMMI Radiopharm Chem 8 (1) 23 [2023-09-21; online 2023-09-21]

Olof Eriksson SciLifeLab Fellow

Year 2020

PubMed DOI Crossref

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.

Garousi J, Orlova A, Frejd FY, Tolmachev V

EJNMMI Radiopharm Chem 5 (1) 16 [2020-06-23; online 2020-06-23]